CN100490828C - 一种治疗痔疮的外用药物及其制备工艺和质量检测方法 - Google Patents
一种治疗痔疮的外用药物及其制备工艺和质量检测方法 Download PDFInfo
- Publication number
- CN100490828C CN100490828C CNB2006101702064A CN200610170206A CN100490828C CN 100490828 C CN100490828 C CN 100490828C CN B2006101702064 A CNB2006101702064 A CN B2006101702064A CN 200610170206 A CN200610170206 A CN 200610170206A CN 100490828 C CN100490828 C CN 100490828C
- Authority
- CN
- China
- Prior art keywords
- weight portions
- powder
- borneolum syntheticum
- suspended matter
- succinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims description 52
- 238000001514 detection method Methods 0.000 title abstract 2
- 239000000843 powder Substances 0.000 claims abstract description 167
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 127
- 238000003756 stirring Methods 0.000 claims abstract description 99
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 112
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 102
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 100
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 99
- 244000293323 Cosmos caudatus Species 0.000 claims description 75
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 75
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 69
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 50
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 50
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 50
- 229940057995 liquid paraffin Drugs 0.000 claims description 50
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 50
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 50
- 239000003871 white petrolatum Substances 0.000 claims description 50
- 239000000839 emulsion Substances 0.000 claims description 32
- 239000002674 ointment Substances 0.000 claims description 32
- 239000002671 adjuvant Substances 0.000 claims description 26
- 230000002421 anti-septic effect Effects 0.000 claims description 24
- 235000011837 pasties Nutrition 0.000 claims description 23
- 208000014617 hemorrhoid Diseases 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- 239000000829 suppository Substances 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 7
- 238000010438 heat treatment Methods 0.000 abstract description 7
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 132
- 239000000243 solution Substances 0.000 description 128
- 239000000203 mixture Substances 0.000 description 83
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 66
- 238000012360 testing method Methods 0.000 description 58
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
- 229960004756 ethanol Drugs 0.000 description 45
- 239000013558 reference substance Substances 0.000 description 42
- 239000003921 oil Substances 0.000 description 39
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 24
- 238000009472 formulation Methods 0.000 description 24
- 239000008194 pharmaceutical composition Substances 0.000 description 24
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 239000007788 liquid Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- 239000000341 volatile oil Substances 0.000 description 18
- 238000005406 washing Methods 0.000 description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000007921 spray Substances 0.000 description 12
- 238000004809 thin layer chromatography Methods 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 8
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 7
- 229960003168 bronopol Drugs 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 6
- 239000004380 Cholic acid Substances 0.000 description 6
- 235000003143 Panax notoginseng Nutrition 0.000 description 6
- 241000180649 Panax notoginseng Species 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 6
- 235000019416 cholic acid Nutrition 0.000 description 6
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 6
- 229960002471 cholic acid Drugs 0.000 description 6
- 229960003964 deoxycholic acid Drugs 0.000 description 6
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 229930182494 ginsenoside Natural products 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 230000001788 irregular Effects 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 239000004287 Dehydroacetic acid Substances 0.000 description 5
- 206010018691 Granuloma Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229940061632 dehydroacetic acid Drugs 0.000 description 5
- 235000019258 dehydroacetic acid Nutrition 0.000 description 5
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 5
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- -1 liquid paraffin Chemical compound 0.000 description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000000114 Pain Threshold Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000037040 pain threshold Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000581650 Ivesia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101702064A CN100490828C (zh) | 2006-12-25 | 2006-12-25 | 一种治疗痔疮的外用药物及其制备工艺和质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101702064A CN100490828C (zh) | 2006-12-25 | 2006-12-25 | 一种治疗痔疮的外用药物及其制备工艺和质量检测方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101366654A Division CN101543516B (zh) | 2006-12-25 | 2006-12-25 | 一种治疗痔疮的外用药物的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1985857A CN1985857A (zh) | 2007-06-27 |
CN100490828C true CN100490828C (zh) | 2009-05-27 |
Family
ID=38182884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101702064A Active CN100490828C (zh) | 2006-12-25 | 2006-12-25 | 一种治疗痔疮的外用药物及其制备工艺和质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100490828C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1652184A4 (en) | 2003-07-24 | 2007-05-23 | Lg Electronics Inc | RECORD MEDIA WITH A DATA STRUCTURE FOR MANAGING THE PLAYING OF TEXT SUBTITLE DATA RECORDED THEREFOR AND RECORDING AND PLAYBACK METHOD AND DEVICES |
KR20050036277A (ko) | 2003-10-15 | 2005-04-20 | 엘지전자 주식회사 | 고밀도 광디스크의 네비게이션 정보 관리방법 |
CN101352464B (zh) * | 2007-07-27 | 2013-10-09 | 华润片仔癀药业有限公司 | 一种中药组合物的质量检测方法 |
CN102475728B (zh) * | 2009-09-11 | 2013-09-18 | 漳州片仔癀药业股份有限公司 | 片仔癀的检测方法 |
CN103610748B (zh) * | 2013-11-29 | 2015-11-18 | 漳州片仔癀药业股份有限公司 | 一种治疗痔疮的外用制剂的制备方法 |
CN104606382A (zh) * | 2015-01-15 | 2015-05-13 | 孙喜翠 | 一种八宝丹痔疮软膏及其制备方法 |
CN104606270A (zh) * | 2015-01-15 | 2015-05-13 | 孙喜翠 | 一种含有八宝丹的药物组合物、制备方法及其用途 |
CN105079202A (zh) * | 2015-09-17 | 2015-11-25 | 漳州片仔癀药业股份有限公司 | 一种片仔癀痔疮软膏及其制备方法 |
CN110441302B (zh) * | 2018-05-03 | 2021-12-07 | 中国医学科学院药物研究所 | 一种妥洛特罗透皮贴剂无损质量控制方法 |
-
2006
- 2006-12-25 CN CNB2006101702064A patent/CN100490828C/zh active Active
Non-Patent Citations (4)
Title |
---|
片仔癀痔疮软膏止痛消肿功能的疗效观察. 叶玲等.福建医药杂志,第17卷第3期. 1995 |
片仔癀痔疮软膏止痛消肿功能的疗效观察. 叶玲等.福建医药杂志,第17卷第3期. 1995 * |
片仔癀痔疮软膏的质量标准研究. 洪武奇.海峡药学,第14卷第4期. 2002 |
片仔癀痔疮软膏的质量标准研究. 洪武奇.海峡药学,第14卷第4期. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1985857A (zh) | 2007-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100490828C (zh) | 一种治疗痔疮的外用药物及其制备工艺和质量检测方法 | |
Gruber et al. | Uterotonic plants and their bioactive constituents | |
KR100823123B1 (ko) | 생약 조성물 및 그의 제조방법 | |
JP2011519947A (ja) | 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物 | |
JP2015520228A (ja) | 天然抽出物を有効成分として含む毛髪及び頭皮状態改善用組成物、及びその製造方法 | |
KR101164516B1 (ko) | 양명아주 추출물을 함유하는 약학 조성물, 및 이의 제조방법 및 용도 | |
CN101543516B (zh) | 一种治疗痔疮的外用药物的检测方法 | |
JP2006241044A (ja) | エストロゲン様作用剤 | |
JP2006257056A (ja) | エストロゲン様作用剤及び皮膚外用剤組成物 | |
Hsia et al. | Effects of adlay hull extracts on uterine contraction and Ca2+ mobilization in the rat | |
Kong et al. | Potential anti-fertility plants from Chinese medicine | |
CN106535912B (zh) | 控制人体血脂和体重的药物组合物及其应用 | |
CN101313938B (zh) | 辛夷挥发油鼻喷剂 | |
CN102058822A (zh) | 一种用于健胃消食的药物组合物 | |
Chothani et al. | Phytochemical screening and quantification of phytoconstituents in Gmelina arborea fruits extracts | |
Bafor et al. | Medicinal plants and their agents that affect uterine contractility | |
CN102048843B (zh) | 一种用于止痛消肿的青鹏贴膏剂及其制备方法 | |
CN107998269A (zh) | 一种具有降血压降血脂防治心脑血管疾病的中药组合物 | |
JP4837930B2 (ja) | 抗エストロゲン作用剤 | |
CN109528917B (zh) | 一种治疗类风湿性关节炎的朝医方组合物及其乳膏剂的制备方法 | |
CN1239189C (zh) | 一种治疗子宫内膜异位症的中药组合物及其制备方法 | |
CN104983725B (zh) | 一种具有抗痛经功效的药物组合物及其制备方法 | |
CN109125443A (zh) | 一种治疗银屑病的中药组合物 | |
Malviya et al. | Evaluation of anti-inflammatory potential of Trigonella foenum-graecum (Fenugreek) seed extracts by using carrageenan induced rat paw edema. | |
CN116270849B (zh) | 一种治疗癌痛膏药的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HUARUN PIENTZEHUANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHONGZHOU PIANZIGUANG PHARMACEUTICAL INDUSTRY CO., LTD. Effective date: 20120815 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120815 Address after: 363000, Jing County, Nanjing County, Fujian, Zhangzhou Patentee after: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. Address before: 363000 Zhangzhou street, Fujian Patentee before: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070627 Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. Contract record no.: 2014990000154 Denomination of invention: Externally applied medicine for treating piles and its preparing process and quality detection method Granted publication date: 20090527 License type: Exclusive License Record date: 20140327 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. Contract record no.: 2014990000154 Date of cancellation: 20171016 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070627 Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. Contract record no.: 2017990000409 Denomination of invention: Externally applied medicine for treating piles and its preparing process and quality detection method Granted publication date: 20090527 License type: Exclusive License Record date: 20171024 |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 363000, Jing County, Nanjing County, Fujian, Zhangzhou Patentee after: Fujian pianzehuang Health Technology Co.,Ltd. Address before: 363000, Jing County, Nanjing County, Fujian, Zhangzhou Patentee before: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: China Resources Pien Tze Huang Pharmaceutical Co.,Ltd. Contract record no.: 2017990000409 Date of cancellation: 20200904 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070627 Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: Fujian pianzehuang Health Technology Co.,Ltd. Contract record no.: X2020990000477 Denomination of invention: A kind of external medicine for treating hemorrhoids and its preparation process and quality detection method Granted publication date: 20090527 License type: Exclusive License Record date: 20200904 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CP01 | Change in the name or title of a patent holder |
Address after: 18/F, Pianzihuang Building, No. 1 Amber Road, Xiangcheng District, Zhangzhou City, Fujian Province, 363000 Patentee after: Fujian pianzehuang Health Technology Co.,Ltd. Address before: 18/F, Pianzihuang Building, No. 1 Amber Road, Xiangcheng District, Zhangzhou City, Fujian Province, 363000 Patentee before: Fujian Pianzihuang Health Industry Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230321 Address after: 18/F, Pianzihuang Building, No. 1 Amber Road, Xiangcheng District, Zhangzhou City, Fujian Province, 363000 Patentee after: Fujian Pianzihuang Health Industry Co.,Ltd. Address before: 363000 Jingcheng New District, Nanjing County, Zhangzhou City, Fujian Province Patentee before: Fujian pianzehuang Health Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: Fujian pianzehuang Health Technology Co.,Ltd. Contract record no.: X2020990000477 Date of cancellation: 20230928 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070627 Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Assignor: Fujian pianzehuang Health Technology Co.,Ltd. Contract record no.: X2023350000370 Denomination of invention: A topical drug for treating hemorrhoids and its preparation process and quality testing method Granted publication date: 20090527 License type: Exclusive License Record date: 20231008 |